Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 17;24(8):7398.
doi: 10.3390/ijms24087398.

Elevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection

Botond Barna Mátyás  1   2   3 , Imre Benedek  1   2   4 , Emanuel Blîndu  1   2   3 , Renáta Gerculy  1   2   3 , Aurelian Roșca  1   2   3 , Nóra Rat  1   2   4 , István Kovács  1   2   4 , Diana Opincariu  2   4 , Zsolt Parajkó  1   2   3 , Evelin Szabó  1   2   3 , Bianka Benedek  5 , Theodora Benedek  1   2   4
Affiliations

Elevated FAI Index of Pericoronary Inflammation on Coronary CT Identifies Increased Risk of Coronary Plaque Vulnerability after COVID-19 Infection

Botond Barna Mátyás et al. Int J Mol Sci. .

Abstract

Inflammation is a key factor in the development of atherosclerosis, a disease characterized by the buildup of plaque in the arteries. COVID-19 infection is known to cause systemic inflammation, but its impact on local plaque vulnerability is unclear. Our study aimed to investigate the impact of COVID-19 infection on coronary artery disease (CAD) in patients who underwent computed tomography angiography (CCTA) for chest pain in the early stages after infection, using an AI-powered solution called CaRi-Heart®. The study included 158 patients (mean age was 61.63 ± 10.14 years) with angina and low to intermediate clinical likelihood of CAD, with 75 having a previous COVID-19 infection and 83 without infection. The results showed that patients who had a previous COVID-19 infection had higher levels of pericoronary inflammation than those who did not have a COVID-19 infection, suggesting that COVID-19 may increase the risk of coronary plaque destabilization. This study highlights the potential long-term impact of COVID-19 on cardiovascular health, and the importance of monitoring and managing cardiovascular risk factors in patients recovering from COVID-19 infection. The AI-powered CaRi-Heart® technology may offer a non-invasive way to detect coronary artery inflammation and plaque instability in patients with COVID-19.

Keywords: COVID-19; chronic coronary syndrome; fat attenuation index; pericoronary adipose tissue; plaque vulnerability; thrombosis; vascular inflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
Conventional CCTA image of the three major coronary arteries (a) and a colored mapping representation of an abnormal FAI for the same patient (b). Figure shows CCTA images of the three major coronary arteries with a stable atherosclerotic lesion (yellow arrows) in a patient who had a COVID-19 infection a few months prior to CCTA examination (a) and delineated pericoronary fat with the FAI colored mapping around the non-culprit lesions (blue arrows) demonstrating abnormal FAI in the same patient (b). Using the CaRi-Heart® v2.4.2 platform (panel b), FAI-Score was evaluated for each individual at baseline in the proximal LAD, LCX, and RCA.
Figure 2
Figure 2
Nomograms with percentile curves for FAI-Score, adjusted for age, gender, and risk factors for each major coronary territory.
Figure 3
Figure 3
PVAT-FAI Score Centile of Coronary Inflammation for each coronary artery.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Spagnoli L.G., Bonanno E., Sangiorgi G., Mauriello A. Role of inflammation in atherosclerosis. J. Nucl. Med. 2007;48:1800–1815. doi: 10.2967/jnumed.107.038661. - DOI - PubMed
    1. Arbab-Zadeh A., Fuster V. From Detecting the Vulnerable Plaque to Managing the Vulnerable Patient: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2019;74:1582–1593. doi: 10.1016/j.jacc.2019.07.062. - DOI - PubMed
    1. Naghavi M., Libby P., Falk E. From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672. doi: 10.1161/01.CIR.0000087480.94275.97. - DOI - PubMed
    1. O’Connel J.L., Pehna de Aleida R., Roever L. The challenge to detect and to treat vulnerable plaques and vulnerable patients. Interv. Cardiol. 2016;8:721–723.
    1. Benedek T., Maurovich Horvath P., Ferdinandy P., Merkely B. The Use of Biomarkers for the Early Detection of Vulnerable Atherosclerotic Plaques and Vulnerable Patients. A Review. J. Cardiovasc. Emerg. 2016;2:106–113. doi: 10.1515/jce-2016-0017. - DOI